Patent 7691964 was granted and assigned to New York University on April, 2010 by the United States Patent and Trademark Office.
Disclosed herein are isolated, purified peptides, biologically active fragments and analogs of the peptides having anti-tumor activity in mammals, pharmaceutical formulations comprising the peptides, fragments and analogs and methods of treating mammals suffering from tumors using such materials.